![Pascal Touchon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pascal Touchon
Direktor/Vorstandsmitglied bei
IPSEN
Vermögen: 910 679 $ am 31.05.2026
Profil
Pascal Touchon is currently an Independent Director at MedinCell SA since 2025 and a Director at Ipsen SA since 2023.
Former roles include Chairman at Atara Biotherapeutics, Inc. from 2024 to 2025, and Director positions at Navigate BioPharma Services, Inc., Genoptix, Inc., Cogen Immune Medicine, Inc., Dantari, Inc., and Novartis Oncology, Inc. as SVP-Global Head Cell & Gene.
Education includes an MBA from INSEAD and a doctorate from Université Toulouse III - Paul Sabatier.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.06.2025 | 77’955 ( 0.87% ) | 819 307 $ | 31.05.2026 | |
IPSEN SA 0% | 31.12.2025 | 500 ( 0% ) | 91 372 $ | 31.05.2026 |
Aktive Positionen von Pascal Touchon
| Unternehmen | Position | Beginn |
|---|---|---|
| IPSEN | Direktor/Vorstandsmitglied | 01.10.2023 |
| MEDINCELL S.A. | Direktor/Vorstandsmitglied | 01.03.2025 |
Ehemalige bekannte Positionen von Pascal Touchon
| Unternehmen | Position | Ende |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Vorstandsvorsitzender | 09.09.2024 |
Cogen Immune Medicine, Inc.
 Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Develops immune medicines | Direktor/Vorstandsmitglied | 01.02.2020 |
Navigate Biopharma Services, Inc.
 Navigate Biopharma Services, Inc. BiotechnologyHealth Technology Operates as a testing laboratory that designs biomarker solutions | Direktor/Vorstandsmitglied | - |
Dantari, Inc.
 Dantari, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in creating breakthrough medicines for the treatment of cancer and serious diseases | Direktor/Vorstandsmitglied | - |
Genoptix, Inc.
 Genoptix, Inc. Medical SpecialtiesHealth Technology Provides personalized medicine services | Direktor/Vorstandsmitglied | - |
Ausbildung von Pascal Touchon
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
33
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Genoptix, Inc.
Genoptix, Inc. Medical SpecialtiesHealth Technology Provides personalized medicine services | Health Technology |
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Toulouse III - Paul Sabatier
 Université Toulouse III - Paul Sabatier Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MedinCell SA
 MedinCell SA Pharmaceuticals: MajorHealth Technology Provides therapeutic solutions | Health Technology |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Develops immune medicines | Health Technology |
Navigate Biopharma Services, Inc.
Navigate Biopharma Services, Inc. BiotechnologyHealth Technology Operates as a testing laboratory that designs biomarker solutions | Health Technology |
Dantari, Inc.
Dantari, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in creating breakthrough medicines for the treatment of cancer and serious diseases | Health Technology |
